Loyd Kelly William forfeited 12,300 shares of Evolution Petroleum Corp (AMEX: EPM) on Sep 1, 2026. The transaction involved the company’s president and CEO, and the reported ownership figure after the event was 417,228 shares.
Bhalla Vikas sold 10,000 shares of ExlService Holdings, Inc (NASDAQ: EXLS). at $38.17 per share on September 1. Vikas, president of EXL, held 120,295 shares after the transaction.
Fabrinet (NYSE: FN) executive Edward T. Archer sold 2,500 shares across two transactions. The sales were completed at prices ranging from $385.58 to $386.34 per share.
Finance of America Companies Inc. (NYSE: FOA) President Sieffert Kristen N held 124,762 shares after selling part of her position. The transaction involved 750 shares at $17.55 per share.
Sloan Samantha L. executive vice president of corporate affairs at First Solar, held 2,353 First Solar shares after a transaction completed on September 1, 2026. The sequence included an option exercise, a share forfeiture and an exercise involving derivative securities.
Flutter Entertainment plc (NYSE: FLUT) Chief Financial Officer Coldrake Robert sold 710 shares in a transaction that left him holding 22,778 shares. The shares changed hands at $97.86 apiece, with the transaction completed on September 1, 2026.
EHealth, Inc. (NASDAQ: EHTH) awarded Chief Financial Officer Dolan John Joseph 70,000 shares at $0 per share. The transaction dated September 1, 2026, leaves Joseph with reported ownership of 343,275 eHealth shares.
Cunniff James L. forfeited 2,671 shares of Electromed, Inc (AMEX: ELMD). in an insider transaction dated September 1, 2026. The shares were valued at $27.10 each. Following the transaction, Cunniff owned 145,080 shares.
Entrada Therapeutics, Inc. (NASDAQ: TRDA) reported the forfeiture of 2,079 shares by Sethuraman Natarajan, its president of research and development. The transaction took place at $7.14 per share.
MPM BIOVENTURES 2018, L.P. sold 86,482 shares of Entrada Therapeutics, Inc (NASDAQ: TRDA). through separate transactions covering Sep 1 through Sep 3, 2026. The reported prices ranged from $7.06 to $7.19 per share, and the filing identifies MPM BIOVENTURES 2018, L.P. as an insider …